Boston Scientific Restructures Business Segments, Appoints New COO
What happened
Boston Scientific announced a reorganization of its business segments, appointing Joseph Fitzgerald as executive vice president and chief operating officer, effective January 1. Fitzgerald previously served as executive vice president and group president of cardiovascular. The company will establish three reportable business segments: Interventional Therapies, Rhythm Solutions, and MedSurg.
From wbjournal.com
Why it matters
The corporate changes are intended to speed up decision-making and assist the company in allocating investments across its product portfolio. Lance Bates will lead the Interventional Therapies segment, which includes Penumbra following the acquisition.
From wbjournal.com
Who's involved
- Boston ScientificWorldwide developer and manufacturer of medical devices undergoing reorganization.
- Joseph FitzgeraldAppointed executive vice president and chief operating officer of Boston Scientific.
- Lance BatesWill lead the newly established Interventional Therapies segment.
- Mike MahoneyServes as the Chairman and CEO of Boston Scientific.
Keep exploring
The entities involved
-
Boston Scientific
worldwide developer, manufacturer and marketer of medical devices
- Corporate restructuring news includes the transformation of CORDIS from a division of Cardinal Health, the acquisitions of Guidant by Boston Scientific and Abbott Laboratories, and appointments involving Cirtec Medical.
- Healthcare companies Boston Scientific and Sysmex Corporation are being compared by analysts.
-
Joseph Fitzgerald
American handball player
Nothing else this week.